The Chemical Biology of NAD Regulation in Axon Degeneration

Overview

Journal Curr Opin Chem Biol

Publisher Elsevier

Specialty Biochemistry

Date 2022 Jul 3

PMID 35780654

Authors

Janneke D Icso

Paul R Thompson

Affiliations

Soon will be listed here.

Abstract

During axon degeneration, NAD levels are largely controlled by two enzymes: nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) and sterile alpha and toll interleukin motif containing protein 1 (SARM1). NMNAT2, which catalyzes the formation of NAD from NMN and ATP, is actively degraded leading to decreased NAD levels. SARM1 activity further decreases the concentration of NAD by catalyzing its hydrolysis to form nicotinamide and a mixture of ADPR and cADPR. Notably, SARM1 knockout mice show decreased neurodegeneration in animal models of axon degeneration, highlighting the therapeutic potential of targeting this novel NAD hydrolase. This review discusses recent advances in the SARM1 field, including SARM1 structure, regulation, and catalysis as well as the identification of the first SARM1 inhibitors.

Citing Articles

Lyssavirus M protein degrades neuronal microtubules by reprogramming mitochondrial metabolism.

Yuan Y, Fang A, Wang H, Wang C, Sui B, Zhao J mBio. 2024; 15(3):e0288023.

PMID: 38349129 PMC: 10936203. DOI: 10.1128/mbio.02880-23.

Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucoma.

Zeng H, Mayberry J, Wadkins D, Chen N, Summers D, Kuehn M Acta Neuropathol Commun. 2024; 12(1):23.

PMID: 38331947 PMC: 10854189. DOI: 10.1186/s40478-024-01736-9.

Genetic ablation of Sarm1 attenuates expression and mislocalization of phosphorylated TDP-43 after mouse repetitive traumatic brain injury.

Dogan E, Bouley J, Zhong J, Harkins A, Keeler A, Bosco D Acta Neuropathol Commun. 2023; 11(1):206.

PMID: 38124145 PMC: 10731794. DOI: 10.1186/s40478-023-01709-4.

NAD, Axonal Maintenance, and Neurological Disease.

Alexandris A, Koliatsos V Antioxid Redox Signal. 2023; 39(16-18):1167-1184.

PMID: 37503611 PMC: 10715442. DOI: 10.1089/ars.2023.0350.

NAD metabolism: Role in senescence regulation and aging.

Chini C, Cordeiro H, Tran N, Chini E Aging Cell. 2023; 23(1):e13920.

PMID: 37424179 PMC: 10776128. DOI: 10.1111/acel.13920.

References

Sporny M, Guez-Haddad J, Lebendiker M, Ulisse V, Volf A, Mim C . Structural Evidence for an Octameric Ring Arrangement of SARM1. J Mol Biol. 2019; 431(19):3591-3605. DOI: 10.1016/j.jmb.2019.06.030. View

Calcraft P, Ruas M, Pan Z, Cheng X, Arredouani A, Hao X . NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature. 2009; 459(7246):596-600. PMC: 2761823. DOI: 10.1038/nature08030. View

Hughes R, Bosanac T, Mao X, Engber T, DiAntonio A, Milbrandt J . Small Molecule SARM1 Inhibitors Recapitulate the SARM1 Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate. Cell Rep. 2021; 34(1):108588. PMC: 8179325. DOI: 10.1016/j.celrep.2020.108588. View

Figley M, Gu W, Nanson J, Shi Y, Sasaki Y, Cunnea K . SARM1 is a metabolic sensor activated by an increased NMN/NAD ratio to trigger axon degeneration. Neuron. 2021; 109(7):1118-1136.e11. PMC: 8174188. DOI: 10.1016/j.neuron.2021.02.009. View

Cheng Y, Liu J, Luan Y, Liu Z, Lai H, Zhong W . Gene Deficiency Attenuates Diabetic Peripheral Neuropathy in Mice. Diabetes. 2019; 68(11):2120-2130. PMC: 6804630. DOI: 10.2337/db18-1233. View

Bratkowski M, Xie T, Thayer D, Lad S, Mathur P, Yang Y . Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1. Cell Rep. 2020; 32(5):107999. DOI: 10.1016/j.celrep.2020.107999. View

George E, Glass J, Griffin J . Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci. 1995; 15(10):6445-52. PMC: 6577979. View

Villegas R, Martinez N, Lillo J, Pihan P, Hernandez D, Twiss J . Calcium release from intra-axonal endoplasmic reticulum leads to axon degeneration through mitochondrial dysfunction. J Neurosci. 2014; 34(21):7179-89. PMC: 4028495. DOI: 10.1523/JNEUROSCI.4784-13.2014. View

Gilley J, Jackson O, Pipis M, Estiar M, Al-Chalabi A, Danzi M . Enrichment of alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders. Elife. 2021; 10. PMC: 8735862. DOI: 10.7554/eLife.70905. View

10.

Loring H, Parelkar S, Mondal S, Thompson P . Identification of the first noncompetitive SARM1 inhibitors. Bioorg Med Chem. 2020; 28(18):115644. PMC: 7443514. DOI: 10.1016/j.bmc.2020.115644. View

11.

Zechel D, Withers S . Glycosidase mechanisms: anatomy of a finely tuned catalyst. Acc Chem Res. 2000; 33(1):11-8. DOI: 10.1021/ar970172+. View

12.

Patel S, Marchant J, Brailoiu E . Two-pore channels: Regulation by NAADP and customized roles in triggering calcium signals. Cell Calcium. 2010; 47(6):480-90. PMC: 2921607. DOI: 10.1016/j.ceca.2010.05.001. View

13.

Essuman K, Summers D, Sasaki Y, Mao X, DiAntonio A, Milbrandt J . The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD Cleavage Activity that Promotes Pathological Axonal Degeneration. Neuron. 2017; 93(6):1334-1343.e5. PMC: 6284238. DOI: 10.1016/j.neuron.2017.02.022. View

14.

Jiang Y, Liu T, Lee C, Chang Q, Yang J, Zhang Z . The NAD-mediated self-inhibition mechanism of pro-neurodegenerative SARM1. Nature. 2020; 588(7839):658-663. DOI: 10.1038/s41586-020-2862-z. View

15.

Hopkins E, Gu W, Kobe B, Coleman M . A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity. Front Mol Biosci. 2021; 8:703532. PMC: 8295901. DOI: 10.3389/fmolb.2021.703532. View

16.

Osterloh J, Yang J, Rooney T, Fox A, Adalbert R, Powell E . dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science. 2012; 337(6093):481-4. PMC: 5225956. DOI: 10.1126/science.1223899. View

17.

Zhao Y, He W, Zhao Z, Li W, Wang Q, Hou Y . Acidic pH irreversibly activates the signaling enzyme SARM1. FEBS J. 2021; 288(23):6783-6794. DOI: 10.1111/febs.16104. View

18.

Canto C, Menzies K, Auwerx J . NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab. 2015; 22(1):31-53. PMC: 4487780. DOI: 10.1016/j.cmet.2015.05.023. View

19.

Fernandes K, Mitchell K, Patel A, Marola O, Shrager P, Zack D . Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury. Exp Eye Res. 2018; 171:54-61. PMC: 5964014. DOI: 10.1016/j.exer.2018.03.007. View

20.

Coleman M, Hoke A . Programmed axon degeneration: from mouse to mechanism to medicine. Nat Rev Neurosci. 2020; 21(4):183-196. PMC: 8926152. DOI: 10.1038/s41583-020-0269-3. View